Pediatric endocrinology

Prevalence and Changes in Genetic and Clinical Characteristics in Growth Hormone-Treated Belgian Girls with Turner Syndrome: A Study from the BELGROW Registry

Horm Res PaediatrPublished Retrospective registry cohort study

Authors' conclusion

Genotype distribution and timing of TS diagnosis have significantly changed since 1991, while the annual number of girls starting GH therapy has remained stable. A 45,X karyotype is associated with earlier diagnosis and more comorbidities.

Study context

Population
Growth hormone (GH)-treated girls with Turner syndrome (TS) in BELGROW, the Belgian national GH registry, 1985–2022
Participants
716 participants
Exposure
1991-2002 vs 2003-2017 period
  • Group 1n = 250reference
  • Group 2n = 270
Outcome
Trends in karyotype, age at diagnosis and phenotype over three decades
Methodological detailsnationwide, multicenter, registry-based (BELGROW)
  • Nationwide
  • Multicenter
  • Registry-based (BELGROW)

Main finding

As reported in the abstract

Karyotype, age at diagnosis and phenotype
Annual number of girls with TS starting GH remained stable (mean n/year)
19
Monosomy 45,X (entire cohort)
44%
Structural X anomalies
27%
45,X/46,XX mosaicism
13%
Triple X mosaicism
4%
45,X/46,XY or complex Y anomalies
6%
Other karyotypes
6%
Median age at diagnosis
6.4 years
Diagnosed prenatally
7.6%
Diagnosed before age 1
24%
Diagnosed in childhood
49%
Diagnosed after 12 years
19%

Observational data: associations, not effects.

Further findings

OutcomeP value
Age at diagnosis by karyotype45,X vs Other genotypes · earlier with 45,X (median 2.2 vs. 8 years)P < 0.001

Affected organ systems

Skeletal
73%
Neurosensory
60%
Cardiac
29%
Skeletal malformations more frequent with 45,X
P < 0.05
Cardiac malformations more frequent with 45,X
P < 0.01

Original publication

Prevalence and Changes in Genetic and Clinical Characteristics in Growth Hormone-Treated Belgian Girls with Turner Syndrome: A Study from the BELGROW Registry. Horm Res Paediatr. Published 23 January 2026. doi:10.1159/000550509

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.